Current Concepts in the Therapy of Multiple Myeloma (Q40049534)

16 September 2017

1 reference

title

Current concepts in the therapy of multiple myeloma (English)

1 reference

16 September 2017

Current Concepts in the Therapy of Multiple Myeloma (English)

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)33105-4

4 May 2023

author name string

H. E. Finkel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5339191

4 May 2023

W. J. Yount

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5339191

4 May 2023

S. E. Salmon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5339191

4 May 2023

A. Schilling

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5339191

4 May 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5339191

4 May 2023

publication date

1 November 1966

1 reference

full work available at URL

16 September 2017

https://api.elsevier.com/content/article/PII:S0025712516331054?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)33105-4

https://api.elsevier.com/content/article/PII:S0025712516331054?httpAccept=text/plain

4 May 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)33105-4

Medical Clinics of North America

4 May 2023

published in

1 reference

16 September 2017

volume

50

1 reference

16 September 2017

issue

6

1 reference

16 September 2017

page(s)

1569-1578

1 reference

The management of multiple myeloma

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

Cyto-active amino-acid and peptide derivatives. Part I. Substituted phenylalanines

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

MYELOMA PROTEINS AND THE CLINICAL RESPONSE TO MELPHALAN THERAPY

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

Studies of the anemia of multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

INDUCTION OF SUBACUTE SKELETAL FLUOROSIS IN A CASE OF MULTIPLE MYELOMA

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

INFECTION, ANTIBODY RESPONSE AND GAMMA GLOBULIN COMPONENTS IN MULTIPLE MYELOMA AND MACROGLOBULINEMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

Inorganic Phosphate Treatment of Hypercalcemia of Diverse Etiologies

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

H CHAIN SUBGROUPS OF MYELOMA PROTEINS AND NORMAL 7S γ-GLOBULIN

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

STUDIES ON AN INTERMITTENT CORTICOSTEROID DOSAGE REGIMEN

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

A comparative study of optimal medical care with and without azaserine in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

STUDIES ON THE ANTI-TUMOUR ACTIVITY OF p-DI-(2-CHLOROETHYL) AMINOPHENYLALANINE (SARCOLYSINE)

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

CLASSIFICATION OF MYELOMA PROTEINS, BENCE JONES PROTEINS, AND MACROGLOBULINS INTO TWO GROUPS ON THE BASIS OF COMMON ANTIGENIC CHARACTERS.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

The management of multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

Plasma-cell myeloma. II. Clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

Plasma-cell myeloma and macroglobulinemia. I. Physicochemical, immunochemical and isotopic turnover studies of the abnormal serum and urinary proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

Multiple myeloma. III. Effect of urethane therapy on plasma cell growth, abnormal serum protein components and Bence Jones proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

Low-molecular-weight proteins related to Bence Jones proteins in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

MELPHALAN IN THE TREATMENT OF MYELOMATOSIS

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

SUBCLASSES OF HUMAN GAMMA-2-GLOBULIN BASED ON DIFFERENCES IN THE HEAVY POLYPEPTIDE CHAINS

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

The clinical usefulness of ACTH and cortisone

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

MELPHALAN THERAPY IN MYELOMATOSIS.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2933105-4

7 January 2021

Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806)

6

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)33105-4

EVALUATION OF MELPHALAN (NSC-8806) IN TREATMENT OF MULTIPLE MYELOMA

4 May 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)33105-4

NOMENCLATURE FOR HUMAN IMMUNOGLOBULINS

4 May 2023

9

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)33105-4

INFLUENCE OF ALKYLATING AGENTS ON KIDNEY ERYTHROPOIETIN PRODUCTION

4 May 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)33105-4

MYELOMA PROTEINS AND ANTIBODIES

4 May 2023

23

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)33105-4

A comparison of the effect of prednisone and a placebo in the treatment of multiple myeloma

4 May 2023

26

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)33105-4

P-(Di-2-chloroethyl) aminophenylbutyric acid (CB 1348) in the treatment of cancer

4 May 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)33105-4

4 May 2023

Identifiers

0 references

1 reference